Coenzyme Q10 for Gulf War Illness: A Replication Study

Coenzyme Q10 for Gulf War Illness: A Replication Study

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

Inclusion Criteria:

• Meets both CDC and Kansas deployment and symptom inclusion criteria.
• Does not have a disqualifying condition.
• Able to travel to a local Quest facility for study blood draws.
• Adequate internet access to allow ZoomPro visit participation and remote survey completion.
• Health prior to the Gulf War rated as "very good" or "excellent" (to exclude persons who may have had other health conditions with different mechanisms as the cause of their symptoms).
• Willing to defer initiation of discretionary treatments or supplements during the expected course of study participation.

Exclusion Criteria:

• Participating in another clinical trial.
• Still-evolving adverse effects following another medication or health condition, such as covid or fluoroquinolone use.
• On Coumadin/ warfarin.
• Unable to participate for the required duration of the study.